| - GRCh37:
- Chr22:17700244
- GRCh38:
- Chr22:17219354
| ADA2 | | Vasculitis due to ADA2 deficiency | Likely pathogenic (May 2, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17684636
- GRCh38:
- Chr22:17203746
| ADA2 | | Vasculitis due to ADA2 deficiency, Sneddon syndrome | Likely benign (Apr 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17669320
- GRCh38:
- Chr22:17188430
| ADA2 | | Vasculitis due to ADA2 deficiency | Likely benign (Apr 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17662373-17672720
| ADA2 | | Vasculitis due to ADA2 deficiency | Uncertain significance (Aug 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17684433-17690567
| ADA2 | | Vasculitis due to ADA2 deficiency | Uncertain significance (Jul 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17669209-17672720
| ADA2 | | Vasculitis due to ADA2 deficiency | Pathogenic (Jul 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17565982-20052185
| ADA2, ARVCF, ATP6V1E1, BCL2L13, BID, C22orf39, CDC45, CECR2, CECR3, CLDN5, CLTCL1, COMT, DGCR2, DGCR6, ESS2, GNB1L, GP1BB, GSC2, HDHD5, HIRA, IL17RA, MICAL3, MRPL40, PEX26, PRODH, RTL10, SEPTIN5, SLC25A1, SLC25A18, TANGO2, TBX1, TMEM121B, TSSK2, TUBA8, TXNRD2, UFD1, USP18 | | Immunodeficiency 51, Vasculitis due to ADA2 deficiency | Pathogenic (Apr 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17662838-17662839
- GRCh38:
- Chr22:17181948-17181949
| ADA2 | I197K, I318K, I396K, I438K | Vasculitis due to ADA2 deficiency | Uncertain significance (Dec 9, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17690541
- GRCh38:
- Chr22:17209651
| ADA2 | | Vasculitis due to ADA2 deficiency | Likely benign (Jun 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17684479
- GRCh38:
- Chr22:17203589
| ADA2 | M123V, M201V, M243V | Vasculitis due to ADA2 deficiency | Uncertain significance (Jul 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17662886
- GRCh38:
- Chr22:17181996
| ADA2 | | Vasculitis due to ADA2 deficiency | Likely benign (Apr 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17684546
- GRCh38:
- Chr22:17203656
| ADA2 | Y100*, Y178*, Y220* | Vasculitis due to ADA2 deficiency | Pathogenic (Sep 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17670843
- GRCh38:
- Chr22:17189953
| ADA2 | G279R, G321R, G201R, G80R | Vasculitis due to ADA2 deficiency | Uncertain significance (Aug 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17672638
- GRCh38:
- Chr22:17191748
| ADA2 | | Vasculitis due to ADA2 deficiency | Likely benign (Jul 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17670823
- GRCh38:
- Chr22:17189933
| ADA2 | | Vasculitis due to ADA2 deficiency | Benign (Oct 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17684566
- GRCh38:
- Chr22:17203676
| ADA2 | I172V, I214V, I94V | Vasculitis due to ADA2 deficiency | Uncertain significance (Jan 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17662900
- GRCh38:
- Chr22:17182010
| ADA2 | V376L, V177L, V298L, V418L | Vasculitis due to ADA2 deficiency | Uncertain significance (Apr 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17688046
- GRCh38:
- Chr22:17207156
| ADA2 | P153S, P33S, P111S | Vasculitis due to ADA2 deficiency | Uncertain significance (Feb 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17688174
- GRCh38:
- Chr22:17207284
| ADA2 | A110V, A68V | Vasculitis due to ADA2 deficiency | Uncertain significance (Jan 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17662707
- GRCh38:
- Chr22:17181817
| ADA2 | | Vasculitis due to ADA2 deficiency | Uncertain significance (May 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17687957
- GRCh38:
- Chr22:17207067
| ADA2 | | Vasculitis due to ADA2 deficiency | Uncertain significance (Aug 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17690270
- GRCh38:
- Chr22:17209380
| ADA2 | N100Y, N58Y | Vasculitis due to ADA2 deficiency | Uncertain significance (Jul 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17688057
- GRCh38:
- Chr22:17207167
| ADA2 | A29V, A107V, A149V | Vasculitis due to ADA2 deficiency | Uncertain significance (Mar 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17662454
- GRCh38:
- Chr22:17181564
| ADA2 | | Vasculitis due to ADA2 deficiency | Likely benign (Apr 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17688148
- GRCh38:
- Chr22:17207258
| ADA2 | V119M, V77M | Vasculitis due to ADA2 deficiency | Uncertain significance (Jun 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17688142
- GRCh38:
- Chr22:17207252
| ADA2 | M79V, M121V, M1V | Vasculitis due to ADA2 deficiency | Uncertain significance (Oct 31, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17690397
- GRCh38:
- Chr22:17209507
| ADA2 | E57D, E15D | Vasculitis due to ADA2 deficiency | Uncertain significance (Jul 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17688088
- GRCh38:
- Chr22:17207198
| ADA2 | T139A, T19A, T97A | Vasculitis due to ADA2 deficiency | Uncertain significance (Sep 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17688166
- GRCh38:
- Chr22:17207276
| ADA2 | L71I, L113I | Vasculitis due to ADA2 deficiency | Uncertain significance (Aug 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17669344
- GRCh38:
- Chr22:17188454
| ADA2 | | Vasculitis due to ADA2 deficiency | Likely benign (Aug 31, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17670900
- GRCh38:
- Chr22:17190010
| ADA2 | A182T, A260T, A302T, A61T | Vasculitis due to ADA2 deficiency | Uncertain significance (Mar 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17688113
- GRCh38:
- Chr22:17207223
| ADA2 | | Vasculitis due to ADA2 deficiency | Likely benign (Aug 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17672687
- GRCh38:
- Chr22:17191797
| ADA2 | S136N, S256N, S15N, S214N | Vasculitis due to ADA2 deficiency | Uncertain significance (Aug 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17672582
- GRCh38:
- Chr22:17191692
| ADA2 | S171L, S249L, S291L, S50L | Vasculitis due to ADA2 deficiency | Uncertain significance (Aug 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17663629
- GRCh38:
- Chr22:17182739
| ADA2 | | Vasculitis due to ADA2 deficiency | Likely benign (Aug 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17690424
- GRCh38:
- Chr22:17209534
| ADA2 | | Vasculitis due to ADA2 deficiency | Likely benign (Jun 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17690493
- GRCh38:
- Chr22:17209603
| ADA2 | | Vasculitis due to ADA2 deficiency | Uncertain significance (Jan 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17670822
- GRCh38:
- Chr22:17189932
| ADA2 | | Vasculitis due to ADA2 deficiency | Likely benign (Apr 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17690457
- GRCh38:
- Chr22:17209567
| ADA2 | | Vasculitis due to ADA2 deficiency | Likely benign (Jun 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17684641
- GRCh38:
- Chr22:17203751
| ADA2 | V189L, V69L, V147L | Vasculitis due to ADA2 deficiency | Uncertain significance (Jun 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17672674
- GRCh38:
- Chr22:17191784
| ADA2 | H19Q, H260Q, H140Q, H218Q | Vasculitis due to ADA2 deficiency | Uncertain significance (Jan 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17669335
- GRCh38:
- Chr22:17188445
| ADA2 | | Vasculitis due to ADA2 deficiency | Likely benign (Sep 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17662917
- GRCh38:
- Chr22:17182027
| ADA2 | | Vasculitis due to ADA2 deficiency | Likely benign (Sep 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17669326
- GRCh38:
- Chr22:17188436
| ADA2 | E208D, E328D, E87D, E286D | Vasculitis due to ADA2 deficiency | Likely pathogenic (Jan 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17690315
- GRCh38:
- Chr22:17209425
| ADA2 | H85D, H43D | Vasculitis due to ADA2 deficiency | Uncertain significance (May 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17669348
- GRCh38:
- Chr22:17188458
| ADA2 | | Vasculitis due to ADA2 deficiency | Likely benign (Mar 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17684626
- GRCh38:
- Chr22:17203736
| ADA2 | E152K, E74K, E194K | Vasculitis due to ADA2 deficiency | Uncertain significance (Mar 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17690400
- GRCh38:
- Chr22:17209510
| ADA2 | | Vasculitis due to ADA2 deficiency | Likely benign (Mar 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17669330
- GRCh38:
- Chr22:17188440
| ADA2 | H327P, H207P, H285P, H86P | Vasculitis due to ADA2 deficiency | Uncertain significance (Jul 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17672604
- GRCh38:
- Chr22:17191714
| ADA2 | I43L, I164L, I242L, I284L | Vasculitis due to ADA2 deficiency | Uncertain significance (Feb 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17690417
- GRCh38:
- Chr22:17209527
| ADA2 | V51L, V9L | Vasculitis due to ADA2 deficiency | Uncertain significance (Aug 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17684563
- GRCh38:
- Chr22:17203673
| ADA2 | S173T, S215T, S95T | Vasculitis due to ADA2 deficiency | Uncertain significance (Feb 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17670824
- GRCh38:
- Chr22:17189934
| ADA2 | | Vasculitis due to ADA2 deficiency | Likely benign (Jul 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17684440
- GRCh38:
- Chr22:17203550
| ADA2 | | Vasculitis due to ADA2 deficiency | Likely benign (Jun 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17670878
- GRCh38:
- Chr22:17189988
| ADA2 | M68T, M189T, M267T, M309T | Vasculitis due to ADA2 deficiency | Uncertain significance (Jul 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17688037
- GRCh38:
- Chr22:17207147
| ADA2 | S114P, S156P, S36P | Vasculitis due to ADA2 deficiency | Uncertain significance (Feb 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17690495
- GRCh38:
- Chr22:17209605
| ADA2 | G25S | Vasculitis due to ADA2 deficiency | Uncertain significance (Jul 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17690495
- GRCh38:
- Chr22:17209605
| ADA2 | G25C | Vasculitis due to ADA2 deficiency | Uncertain significance (Sep 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17690318
- GRCh38:
- Chr22:17209428
| ADA2 | M84V, M42V | Vasculitis due to ADA2 deficiency | Uncertain significance (Oct 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17662698-17662699
- GRCh38:
- Chr22:17181808-17181809
| ADA2 | | Vasculitis due to ADA2 deficiency | Likely benign (Jan 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17690470
- GRCh38:
- Chr22:17209580
| ADA2 | T33I | Vasculitis due to ADA2 deficiency | Uncertain significance (Feb 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17662849
- GRCh38:
- Chr22:17181959
| ADA2 | P194S, P435S, P393S, P315S | Vasculitis due to ADA2 deficiency | Uncertain significance (Feb 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17684530
- GRCh38:
- Chr22:17203640
| ADA2 | D226N, D106N, D184N | Vasculitis due to ADA2 deficiency | Uncertain significance (Dec 20, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17684681
- GRCh38:
- Chr22:17203791
| ADA2 | | Vasculitis due to ADA2 deficiency | Likely benign (Oct 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17662457
- GRCh38:
- Chr22:17181567
| ADA2 | | Vasculitis due to ADA2 deficiency | Likely benign (Sep 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17662881
- GRCh38:
- Chr22:17181991
| ADA2 | H183R, H304R, H382R, H424R | Vasculitis due to ADA2 deficiency | Uncertain significance (Oct 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17662484
- GRCh38:
- Chr22:17181594
| ADA2 | | Vasculitis due to ADA2 deficiency | Likely benign (Sep 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17672561
- GRCh38:
- Chr22:17191671
| ADA2 | | Vasculitis due to ADA2 deficiency | Likely benign (Aug 31, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17669255
- GRCh38:
- Chr22:17188365
| ADA2 | P232fs, P352fs, P310fs, P111fs | Vasculitis due to ADA2 deficiency | Pathogenic (Aug 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17669272
- GRCh38:
- Chr22:17188382
| ADA2 | | Vasculitis due to ADA2 deficiency | Likely benign (Oct 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17690397
- GRCh38:
- Chr22:17209507
| ADA2 | | Vasculitis due to ADA2 deficiency | Likely benign (Oct 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17688164
- GRCh38:
- Chr22:17207274
| ADA2 | | Vasculitis due to ADA2 deficiency | Likely benign (Jun 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17690329
- GRCh38:
- Chr22:17209439
| ADA2 | F38fs, F80fs | Vasculitis due to ADA2 deficiency | Pathogenic (Sep 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17690467
- GRCh38:
- Chr22:17209577
| ADA2 | R34P | Vasculitis due to ADA2 deficiency | Uncertain significance (Oct 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17688051
- GRCh38:
- Chr22:17207161
| ADA2 | P151L, P31L, P109L | Vasculitis due to ADA2 deficiency | Uncertain significance (May 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17669213
- GRCh38:
- Chr22:17188323
| ADA2 | | Vasculitis due to ADA2 deficiency | Likely benign (Jun 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17663653
- GRCh38:
- Chr22:17182763
| ADA2 | | Vasculitis due to ADA2 deficiency | Likely pathogenic (Sep 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17663510
- GRCh38:
- Chr22:17182620
| ADA2 | C408S, C366S, C167S, C288S | Vasculitis due to ADA2 deficiency | Uncertain significance (Jun 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17670935
- GRCh38:
- Chr22:17190045
| ADA2 | | Vasculitis due to ADA2 deficiency | Likely benign (Jul 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17669249-17669252
- GRCh38:
- Chr22:17188359-17188362
| ADA2 | Y112fs, Y353fs, Y233fs, Y311fs | Vasculitis due to ADA2 deficiency | Pathogenic (Jun 12, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17670858
- GRCh38:
- Chr22:17189968
| ADA2 | P274S, P316S, P196S, P75S | Vasculitis due to ADA2 deficiency | Uncertain significance (Apr 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17670920
- GRCh38:
- Chr22:17190030
| ADA2 | S175F, S253F, S295F, S54F | Vasculitis due to ADA2 deficiency | Uncertain significance (May 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17670906
- GRCh38:
- Chr22:17190016
| ADA2 | V180L, V258L, V59L, V300L | Vasculitis due to ADA2 deficiency | Uncertain significance (May 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17663663
- GRCh38:
- Chr22:17182773
| ADA2 | | Vasculitis due to ADA2 deficiency | Likely benign (Sep 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17690251
- GRCh38:
- Chr22:17209361
| ADA2 | P106R, P64R | Vasculitis due to ADA2 deficiency | Uncertain significance (Feb 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17690430-17690431
- GRCh38:
- Chr22:17209540-17209541
| ADA2 | R7fs, R49fs | Vasculitis due to ADA2 deficiency | Pathogenic (Jan 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17663634
- GRCh38:
- Chr22:17182744
| ADA2 | I325V, I247V, I367V, I126V | Vasculitis due to ADA2 deficiency | Uncertain significance (Mar 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17662396
- GRCh38:
- Chr22:17181506
| ADA2 | I385V, I264V, I463V, I505V | Vasculitis due to ADA2 deficiency | Uncertain significance (Jul 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17663524
- GRCh38:
- Chr22:17182634
| ADA2 | | Vasculitis due to ADA2 deficiency | Likely benign (May 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17662436-17662437
- GRCh38:
- Chr22:17181546-17181547
| ADA2 | N371fs, N449fs, N250fs, N491fs | Vasculitis due to ADA2 deficiency | Likely pathogenic (Feb 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17669330
- GRCh38:
- Chr22:17188440
| ADA2 | H327R, H285R, H86R, H207R | Vasculitis due to ADA2 deficiency | Uncertain significance (Jul 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17688188
- GRCh38:
- Chr22:17207298
| ADA2 | | Vasculitis due to ADA2 deficiency | Likely benign (Sep 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17684644
- GRCh38:
- Chr22:17203754
| ADA2 | L146V, L188V, L68V | Autoinflammatory syndrome, Vasculitis due to ADA2 deficiency, Sneddon syndrome
| Uncertain significance (Nov 2, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:17662918
- GRCh38:
- Chr22:17182028
| ADA2 | | Vasculitis due to ADA2 deficiency, Autoinflammatory syndrome | Conflicting interpretations of pathogenicity (May 24, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:17663520
- GRCh38:
- Chr22:17182630
| ADA2 | I164L, I285L, I363L, I405L | Vasculitis due to ADA2 deficiency, Autoinflammatory syndrome | Uncertain significance (Jul 2, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:17684658
- GRCh38:
- Chr22:17203768
| ADA2 | L141P, L183P, L63P | Vasculitis due to ADA2 deficiency | Likely pathogenic (Jun 21, 2022) | no assertion criteria provided |
| - GRCh37:
- Chr22:17663512
- GRCh38:
- Chr22:17182622
| ADA2 | | Vasculitis due to ADA2 deficiency | Likely benign (Mar 16, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17663485
- GRCh38:
- Chr22:17182595
| ADA2 | | Vasculitis due to ADA2 deficiency | Likely benign (Jul 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17663661
- GRCh38:
- Chr22:17182771
| ADA2 | | Vasculitis due to ADA2 deficiency, Sneddon syndrome, Vasculitis due to ADA2 deficiency
| Likely benign (Aug 22, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:17672557
- GRCh38:
- Chr22:17191667
| ADA2 | | Vasculitis due to ADA2 deficiency | Likely benign (May 10, 2021) | criteria provided, single submitter |